Mosunetuzumab
Mosunetuzumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Mosunetuzumab is under investigation in clinical trial NCT03677154 (A Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Therapy in Participants With Previously Untreated Diffuse Large B-Cell Lymphoma Who Are Unable to Tolerate Full-Dose Chemotherapy).
| Trade Name | Mosunetuzumab |
| Generic | Mosunetuzumab |
| Mosunetuzumab Other Names | Mosunetuzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Mosunetuzumab
